Ticker Hub

BDPT

BIOADAPTIVES INC

Latest price

$0.0014-6.67%

As of Oct 26, 2026, 3:55 PM EDT · Market data by Massive

Market cap

—

Volume

1.3M

Previous close

$0.0015

Day range

$0.0014 – $0.0014

Listed

—

Coverage

22 articles

Price performance

Recent trading

5 trading days · 15-minute intervals · ET
$0.0017$0.0016$0.0015$0.0014$0.0014Tue, 10/20Wed, 10/21Thu, 10/22Fri, 10/23Mon, 10/26
Five-day open $0.0016Latest interval $0.0014

Newsroom

Latest BDPT coverage

SCD
NewsFeb 23, 2024

BioAdaptives, Inc. Announces NaturaComplete, an All-In-One Supplement to Optimize Its AI-Based FYO Obesity Management System

[ad_1] Edward Jacobs, M.D., BioAdaptives CEO, comments, “NaturaComplete™ is derived from research conducted over the past seven years and is based on the idea that a single, comprehensive blend of synergistic natural ingredients can provide safe and effective support for the immune system and critical body organs including the Brain, Heart, Lungs, and Liver.

FYOBDPT
BioAdaptives Announces Low-Cost AI FYO Smartphone App Tracking System to Detect Unwanted Muscle Mass Loss Reported With Obesity Management
NewsFeb 5, 2024

BioAdaptives Announces Low-Cost AI FYO Smartphone App Tracking System to Detect Unwanted Muscle Mass Loss Reported With Obesity Management

[ad_1] Free FYO Body Composition Testing for First 100 Subscribers LAS VEGAS, NV – (NewMediaWire) – February 01, 2024 – BioAdaptives, Inc. (OTC: BDPT), a leading manufacturer and distributor of innovative, all-natural dietary supplements, announces a new, Low-Cost AI FYO Smartphone App Tracking System to Detect Unwanted  Muscle Loss Reporte

BDPT
SCD
NewsJan 29, 2024

BioAdaptives' Subsidiary, Livestock Impact, Inc., Celebrates Banner 2023 Equine Championship Titles Attributed to Its Advanced Proprietary Supplement Products

[ad_1] LAS VEGAS, NV – (NewMediaWire) – January 25, 2024 – BioAdaptives Inc. (OTC: BDPT), a leading manufacturer and distributor of
 innovative, all-natural dietary supplements, announces the achievement of
 multiple Equine Championship Titles attributed to the advanced proprietary supplements
 sold by its subsidiary, Livestock

BDPT
SCD
NewsJan 6, 2024

Livestock Impact, Inc., Subsidiary of BioAdaptives, Inc., Launches Innovative Food Lab for Development of Treats and Supplement Powder for Human, Equine, and Canine Products

[ad_1] LAS VEGAS, NV – (NewMediaWire) – January 04, 2024 – BioAdaptives Inc. (OTC: BDPT), a leading manufacturer and distributor of innovative, all-natural dietary supplements, through its wholly owned Subsidiary Livestock Impact, Inc., announces the launch of a specialized R&D Food Lab dedicated to creating natural powder products and trea

BDPT
BioAdaptives, Inc. to Form New Division, AI BodyShape Lab, to Promote Adult Fitness and Weight Management
NewsDec 22, 2023

BioAdaptives, Inc. to Form New Division, AI BodyShape Lab, to Promote Adult Fitness and Weight Management

[ad_1] LAS VEGAS, NV – (NewMediaWire) – December 21, 2023 – BioAdaptives Inc. (OTC: BDPT), a leading manufacturer and distributor of innovative, all-natural dietary supplements, announces the formation of a new business division, AI BodyShape Lab, in January 2024 to promote adult fitness and weight management.   AI BodyShape Lab is position

BDPT
SCD
NewsDec 14, 2023

BioAdaptives, Inc. Introduces PROTEINnMORETM Ahead of 2024 Launch of AI-based "Fit Your Outfit" app

[ad_1] BioAdaptives Anticipates the Launch of Patented AI-Based app in Q1 2024 State-of-the-Art Supplement, PROTEINnMORETM, Enters $20.4 Billion Protein Supplement Market     LAS VEGAS, NV – (NewMediaWire) – December 14, 2023 – BioAdaptives Inc. (OTC: BDPT), a leading manufacturer and distributor of innovative, all-natural dietary supplemen

BDPT
SCD
NewsDec 10, 2023

BioAdaptives Announces Special Holiday Wellness Offers and Gift

[ad_1] LAS VEGAS, NV  – (NewMediaWire) – December 07, 2023 – BioAdaptives, Inc. (OTC: BDPT), a leading manufacturer and distributor of innovative, all-natural dietary supplements, is pleased to announce a special Holiday promotion during December, focusing on enhancing general health: the gift of being back at your best. This year, the comp

BDPT
SCD
NewsNov 18, 2023

BioAdaptives Announces the Development of VeganHepPlusTM Liver Supplement Formula

[ad_1] VeganHepPlusTM is Designed to Detoxify the Liver and Support Healthy Function   The American Association for the Study of Liver Diseases Predict Increase in Chronic Liver Disease Over the Next 25 Years   The Rise of Air Pollution Poses a Significant Threat to Liver Health   LAS VEGAS, NV – (NewMediaWire) – November 16, ...

BDPT
SCD
NewsNov 3, 2023

BioAdaptives Takes Aim at Safe Pain Management with All-Natural Supplement

[ad_1] Company’s PluriPainⓇ supplement delivers fast-acting natural pain relief The World Institute of Pain concluded its 12th World Congress in Turkey this week An estimated 1.5 billion people worldwide are living with chronic pain   LAS VEGAS, NV – (NewMediaWire) – November 2, 2023 – BioAdaptives, Inc. (OTC: BDPT), a leading formulator an

BDPT
SCD
NewsOct 29, 2023

BioAdaptives Targets Multi-Billion Dollar Sleep Market with SleepEZ Natural Supplement

[ad_1] BioAdaptives’ SleepEZ™ Supplement Delivers Natural Sleep Support   Leading Sleep Experts Meet at the World Sleep Congress This Week to Discuss Latest Breakthroughs   Chronic Insomnia Affects an Estimated 30% of the World’s Population   LAS VEGAS, NV – (NewMediaWire) – October 26, 2023 – BioAdaptives, Inc. (OTC:  BDPT), a leading form

BDPT
SCD
NewsOct 2, 2023

BioAdaptives, Inc. Redefines Its Expanding Role of Providing Innovative Human Health Products While Its Wholly Owned Subsidiary, LiveStock Impact, Inc., Targets Animal Health and Botanical Drugs

[ad_1] LAS VEGAS, NV – (NewMediaWire) – September 27, 2023 – BioAdaptives, Inc. (OTCMkts:  BDPT) announced today new directions and activities intended to expand the Company’s role in providing additional products for human health.  Besides continuing to develop and market novel all natural supplement formulations for general use, BDPT is d

LASVEGASNVBDPT
SCD
NewsSep 17, 2023

LiveStock Impact, Inc., a Wholly Owned Subsidiary of BioAdaptives, Inc., Announces the Appointments of two Experts to Board of Directors

[ad_1] Further Strengthening the Board by Providing Additional Experienced Guidance for New Products and Global Marketing LAS VEGAS, NV – (NewMediaWire) – September 14, 2023 – LiveStock Impact, Inc., a wholly owned subsidiary of  BioAdaptives, Inc. (OTCMkts:  BDPT) announced today the appointment of two new members to its Board of Directors

LASVEGASNVBDPT
SCD
NewsSep 8, 2023

BioAdaptives, Inc. Announces the Spin-off Its LiveStock Impact Division as a Wholly Owned Subsidiary, LiveStock Impact, Inc., Focusing on New Product Development and Global Marketing of Animal Health Supplement Products and Botanical Drugs

[ad_1] LAS VEGAS, NV – (NewMediaWire) – September 08, 2023 – BioAdaptives, Inc. (OTCMkts:  BDPT) announced today the spin- off of its LiveStock Impact Division as a wholly owned subsidiary.  The new company, LiveStock Impact, Inc., will pursue additional initiatives and alliances while continuing to develop and market natural supplements fo

LASVEGASNVBDPT
SCD
NewsApr 16, 2023

NewMediaWire | BioAdaptives Inc. (OTC BDPT) Announces New Appointment to the Board of Directors

[ad_1] Las Vegas, NV – (NewMediaWire) – April 13, 2023 – BioAdaptives, Inc. (OTCMkts: BDPT) announced today the appointment of David Allen, PhD to its Board of Directors. Edward Jacobs, M.D., CEO BioAdaptives, Inc., comments, “We are very pleased to be joined by David Allen, PhD on our Board of Directors. David Allen is considered ...

BDPTNV
SCD
NewsApr 9, 2023

NewMediaWire | BioAdaptives, Inc. (OTC BDPT) Announces New Appointment to the Board of Directors

[ad_1] Las Vegas NV – (NewMediaWire) – April 05, 2023 – BioAdaptives, Inc. (OTCMkts:  BDPT) announced today the appointment of Dr.Yaguang Liu to its Board of Directors. Edward Jacobs, M.D., CEO Bioadaptives, Inc., states, “We are extremely fortunate to be joined by Dr. Yaguang Liu on our Board of Directors at this time.  Dr. Liu ...

BDPTNV
BioAdaptives, Inc. Launching Next Generation Products for Natural Health Practitioners
NewsJul 17, 2022

BioAdaptives, Inc. Launching Next Generation Products for Natural Health Practitioners

[ad_1] Enhanced Products For Use by Holistic Healthcare Practitioners – $21b US Market For Alternative Medicine Goods and Services Las Vegas, NV – (NewMediaWire) – July 14, 2022 – BioAdaptives, Inc. (OTCMkts: BDPT) is launching an enhanced product line for holistic healthcare practitioners. The next generation products are more advanced ver

USNVBDPTCOVID
BioAdaptives, Inc. Introduces PrimiSleep, An Advanced Sleep-Aid Designed to Harmonize with the Body's Unique Circadian Rhythm, Delivering Gentle, Sustained, Restorative Sleep With No "Hangover"
NewsJul 7, 2022

BioAdaptives, Inc. Introduces PrimiSleep, An Advanced Sleep-Aid Designed to Harmonize with the Body's Unique Circadian Rhythm, Delivering Gentle, Sustained, Restorative Sleep With No "Hangover"

[ad_1] PrimiSleep™ Enters Rapidly Growing Global Sleep Aid Market With State-of-the-Art Supplement Las Vegas, NV – (NewMediaWire) – July 07, 2022 – BioAdaptives, Inc. (OTCMkts:  BDPT), is pleased to announce the launch of a new, anti-stress, all-natural product, PrimiSleep™, specifically designed to induce relaxation and restful, continuous

NVBDPTREMCOVID
BioAdaptives, Inc. Seeks to Increase Market Share in $1.9 Billion Global Pet Supplements Market With Canine All-In-One Premium Nutraceutical
NewsJun 23, 2022

BioAdaptives, Inc. Seeks to Increase Market Share in $1.9 Billion Global Pet Supplements Market With Canine All-In-One Premium Nutraceutical

[ad_1] Las Vegas, NV – (NewMediaWire) – June 23, 2022 – BioAdaptives, Inc. (OTCMkts: BDPT), has launched its advanced proprietary supplement for dogs, Canine All-in-One, a daily dose formulation, patterned after its highly successful product for horses, Equine All-In-One.  Canine All-In-One has been created by combining its top-selling Cani

NVBDPTCAGRAPPA
BioAdaptives Sponsors COVID-19 Long Hauler Survey
NewsJun 5, 2022

BioAdaptives Sponsors COVID-19 Long Hauler Survey

[ad_1] Las Vegas, NV – (NewMediaWire) – June 02, 2022 – BioAdaptives, Inc. (OTCMkts:  BDPT) announces its sponsorship of the COVID Long Haul Survey conducted by independent medical researcher, Regina Sutton, M.D.  Dr. Sutton, who previously summarized her successful use of PluriPain® to control her own severe pain, “brain fog” and fatigue d

COVIDNVBDPTGDD
SCD
NewsJul 25, 2021

NewMediaWire | BioAdaptives — Livestock Impact Division Announcement

[ad_1] Marketing Initiative and Ambassador Program Las Vegas, NV – (NewMediaWire) – July 22, 2021 – BioAdaptives, Inc. (OTCMkts:  BDPT) announced that its Livestock Impact Division, the marketer of Equine All-in-One™ and Canine Regen® products, has commenced an Ambassador Program outreach marketing program.  The Ambassador Program provides

NVBDPTNCHAABPAR
SCD
NewsJun 10, 2021

NewMediaWire | BioAdaptives Management Additions

[ad_1] Townsend Appointed as COO and Director; Ellis Appointed as President and Director; Lambrecht Appointed as CFO Las Vegas, NV – (NewMediaWire) – June 10, 2021 – BioAdaptives, Inc. (OTCMkts:  BDPT) announced the appointment of Charles Townsend as Chief Operating Officer and as a director.  Robert W. Ellis will remain as President and ha

COOCFONVBDPT
SCD
NewsJun 8, 2021

BioAdaptives Commences Social Media Roll-Out

[ad_1] Targets markets for pain relief and anti-viral/immune defense applications Las Vegas, NV – (NewMediaWire) – June 08, 2021 – BioAdaptives, Inc. (OTCMkts:  BDPT) announced the kick-off of its social media outreach advertising campaign.  J Ramsdell Consulting, Syracuse, New York, and The Dropup Agency, Dallas, Texas, have been brought o

NVBDPTTV
Market data may be delayed and is provided for informational purposes only. SmallCapsDaily content is not investment advice.